Treatment With Prolia(R) (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate Read more about Treatment With Prolia(R) (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate
Amgen Statement on CHMP Opinion on Vectibix(R) (Panitumumab) Use With Chemotherapy in Metastatic Colorectal Cancer Read more about Amgen Statement on CHMP Opinion on Vectibix(R) (Panitumumab) Use With Chemotherapy in Metastatic Colorectal Cancer
Amgen Donates $1 Million to Help Japanese Disaster Victims Read more about Amgen Donates $1 Million to Help Japanese Disaster Victims
Breakaway From Cancer(R) Launches Newly-Enhanced Website Offering Comprehensive, Tailored Support for Cancer Patients Read more about Breakaway From Cancer(R) Launches Newly-Enhanced Website Offering Comprehensive, Tailored Support for Cancer Patients
Amgen to Present at the Cowen and Company 31st Annual Healthcare Conference Read more about Amgen to Present at the Cowen and Company 31st Annual Healthcare Conference
World-Class Professional Golfer Phil Mickelson Launches 'On Course with Phil' for People with Certain Inflammatory Joint and Skin Conditions Read more about World-Class Professional Golfer Phil Mickelson Launches 'On Course with Phil' for People with Certain Inflammatory Joint and Skin Conditions
NBPTS and Amgen Foundation Join to Bolster Science Education Read more about NBPTS and Amgen Foundation Join to Bolster Science Education
Results Published in The Lancet Demonstrate Superiority of XGEVA(TM) (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer Read more about Results Published in The Lancet Demonstrate Superiority of XGEVA(TM) (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer
Amgen to Present at the Citi 2011 Global Healthcare Conference Read more about Amgen to Present at the Citi 2011 Global Healthcare Conference
